Vivian Liu
Directeur/Bestuurslid bij AYTU BIOPHARMA, INC.
Vermogen: 23 643 $ op 30-04-2024
Actieve functies van Vivian Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AYTU BIOPHARMA, INC. | Directeur/Bestuurslid | 01-07-2022 | - |
Independent Dir/Board Member | 01-07-2022 | - | |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Corporate Officer/Principal | - | - |
PREMIA Holdings (Hk) Ltd. | Corporate Officer/Principal | 01-10-2018 | - |
Loopbaan van Vivian Liu
Eerdere bekende functies van Vivian Liu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
THERMOGENESIS HOLDINGS, INC. | Directeur/Bestuurslid | 21-06-2022 | 23-08-2023 |
Independent Dir/Board Member | 21-06-2022 | 23-08-2023 | |
INNOVUS PHARMACEUTICALS INC | Directeur/Bestuurslid | 01-01-2011 | 14-02-2020 |
Algemeen Directeur | 01-01-2011 | 14-02-2020 | |
Financieel Directeur/CFO | 01-01-2011 | 22-01-2013 | |
Independent Dir/Board Member | 01-01-2011 | 14-02-2020 | |
Investor Relations Contact | 01-01-2011 | 22-01-2013 | |
Public Communications Contact | 01-01-2011 | 22-01-2013 | |
President | 01-01-2011 | 22-01-2013 | |
THERMOGENESIS HOLDINGS, INC. | Directeur/Bestuurslid | 03-11-2016 | 16-10-2018 |
Operationeel Directeur | 24-02-2017 | 16-10-2018 | |
Independent Dir/Board Member | 03-11-2016 | 24-02-2017 | |
Bedrijfssecretaris | - | 16-10-2018 | |
Oxonc Services Co LLC
Oxonc Services Co LLC Pharmaceuticals: MajorHealth Technology Part of OxOnc Development LP, Oxonc Services Co LLC is a company that develops pharmaceutical products. The company is based in Princeton, NJ. | Algemeen Directeur | 01-02-2013 | 01-03-2017 |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Algemeen Directeur | 01-01-2007 | 15-12-2009 |
Voorzitter | 15-12-2009 | 01-11-2012 | |
Operationeel Directeur | - | 01-01-2007 | |
Onderzoeksdirecteur - Fxd Inc | - | 01-01-2007 | |
Oprichter | 01-01-1995 | 01-11-2012 | |
President | 01-01-2007 | 15-12-2009 | |
Bedrijfssecretaris | 01-01-2007 | 15-12-2009 | |
FasTrack Pharmaceuticals, Inc.
FasTrack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FasTrack Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company engaged in the development of innovative human therapeutic drugs including drugs to treat liver cancer and autoimmune diseases. Their lead product, PrevOnco, is a H+/K+-ATPase inhibitor, which was granted Orphan Drug Status by the FDA in August 2008. PrevOnco is currently in Phase 3 development as a potential second line therapy for patients with liver cancer. They also have an innovative pipeline of novel products for the Over-the Counter markets including Apeaz and Regia, indicated for pain relief and bleeding of the gums, respectively. | Algemeen Directeur | 01-01-2011 | 01-12-2011 |
President | 01-01-2011 | 01-12-2011 | |
░░░░░░░░░░░░░ ░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - | |
░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | - | - |
Opleiding van Vivian Liu
University of Southern California | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 11 |
Kaaimaneilanden | 2 |
Hongkong | 2 |
Operationeel
Chief Executive Officer | 5 |
Director/Board Member | 5 |
Independent Dir/Board Member | 4 |
Sectoraal
Health Technology | 8 |
Consumer Services | 3 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
THERMOGENESIS HOLDINGS, INC. | Health Technology |
AYTU BIOPHARMA, INC. | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Apricus Biosciences, Inc. is a biopharmaceutical company, which engages in the development and commercialization of product candidates in the areas of specialty urology and rheumatology. Its products include Vitaros and Femprox. The company was founded in 1987 and is headquartered in San Diego, CA. | Health Technology |
Wyche Securities, Inc.
Wyche Securities, Inc. Investment Banks/BrokersFinance Founded in 1996 by Todd Wyche, Brinson Patrick Securities Corp. is an SEC-registered broker/dealer located in New York City. The firm works exclusively with issuers to raise equity capital with little or no impact to stock price, and with a very high level of service and expertise, through their DOCS (Dynamic Offering of Common Stock) at-the-market financing facility. | Finance |
Innovus Pharmaceuticals, Inc.
Innovus Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. Its products focuses in six main categories, including sexual health, pain management, general muscle health, respiratory, sleep, and diabetic care. The company was founded on January 15, 1959 and is headquartered in Englewood, CO. | Health Technology |
FasTrack Pharmaceuticals, Inc.
FasTrack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FasTrack Pharmaceuticals, Inc. is a privately-held specialty pharmaceutical company engaged in the development of innovative human therapeutic drugs including drugs to treat liver cancer and autoimmune diseases. Their lead product, PrevOnco, is a H+/K+-ATPase inhibitor, which was granted Orphan Drug Status by the FDA in August 2008. PrevOnco is currently in Phase 3 development as a potential second line therapy for patients with liver cancer. They also have an innovative pipeline of novel products for the Over-the Counter markets including Apeaz and Regia, indicated for pain relief and bleeding of the gums, respectively. | Health Technology |
OxOnc Development LP
OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Health Technology |
Oxonc Services Co LLC
Oxonc Services Co LLC Pharmaceuticals: MajorHealth Technology Part of OxOnc Development LP, Oxonc Services Co LLC is a company that develops pharmaceutical products. The company is based in Princeton, NJ. | Health Technology |
ThermoGenesis Corp. /California/
ThermoGenesis Corp. /California/ Medical/Nursing ServicesHealth Services ThermoGenesis Corp. engages in the provision of medical laboratories services. The company is headquartered in Rancho Cordova, CA. | Health Services |
PREMIA Holdings (Hk) Ltd. |
- Beurs
- Insiders
- Vivian Liu
- Ervaring